This site uses cookies.
Learn more.

×

This website uses cookies. Some of the cookies we use are essential for parts of the website to operate while others offer you a better browsing experience. You give us your permission to use cookies, by continuing to use our website after you have received the cookie notification. To find out more about cookies on this website and how to change your cookie settings, see our Privacy policy and Terms of Use.

Translating Genetics into Medicine

Translating Genetics into Medicine

Thursday, April 25, 2019, 8:30 AM - 6:00 PM

The New York Academy of Sciences, 7 World Trade Center, 250 Greenwich St Fl 40, New York

Presented By

The Biochemical Pharmacology Discussion Group

The New York Academy of Sciences

 

The first genome-wide association studies (GWASs) began unraveling the genetic basis of complex diseases over a decade ago. In that time, the development of innovative analytical and experimental methods enabled genomic data to inform how genetics relates to human traits, health, and disease. Nevertheless, progress has stalled in translating genetic association signals to an understanding of their underlying biological mechanisms, in identifying causal links between genetic variants and phenotypes, and in developing therapies based on this knowledge — few drug targets identified through GWASs have advanced.

This symposium will highlight emerging strategies to experimentally and computationally identify and validate causal association from patient cohorts, and outline the challenges and opportunities in translating GWAS hits into successful drug discovery programs.

Call for Abstracts

Abstract submissions are invited for a poster session. For complete submission instructions, please visit our online portal. The deadline for abstract submission is Thursday, February 28, 2019.

Earlybird Registration:
117
days
left
Deadline:
103
days
left

Registration

Member
By 03/14/2019
$90
After 03/14/2019
$130
Nonmember Academia, Faculty, etc.
By 03/14/2019
$180
After 03/14/2019
$260
Nonmember Corporate, Other
By 03/14/2019
$250
After 03/14/2019
$350
Nonmember Not for Profit
By 03/14/2019
$180
After 03/14/2019
$260
Nonmember Student, Undergrad, Grad, Fellow
By 03/14/2019
$100
After 03/14/2019
$145
Member Student, Post-Doc, Fellow
By 03/14/2019
$50
After 03/14/2019
$70

Keynote Speaker

Robert Plenge, MD, PhD, Celgene

Speakers

Christopher Brown, PhD, University of Pennsylvania
Molly Gasperini, University of Washington
Matthew Nelson, PhD, MA, GlaxoSmithKline

Scientific Organizing Committee

Judy Cho, MD, Icahn School of Medicine at Mount Sinai
Caroline Fox, MD, Merck Research Labs
Paolo Guarnieri, MD, Boehringer Ingelheim
Julie Hawkins, PhD, Boehringer Ingelheim
Tuuli Lappalainen, PhD, Columbia University; The New York Genome Center
Alan Shuldiner, MD, Regeneron Pharmaceuticals and University of Maryland
Dawn Waterworth, PhD, Glaxo Smith Kline
Alison Carley, PhD, The New York Academy of Sciences
Sonya Dougal, PhD,
The New York Academy of Sciences